Literature DB >> 25321172

Nanomedicine strategies for targeting skin inflammation.

Mona Ma Abdel-Mottaleb1, Celine Try, Yann Pellequer, Alf Lamprecht.   

Abstract

Topical treatment of skin diseases is an attractive strategy as it receives high acceptance from patients, resulting in higher compliance and therapeutic outcomes. Recently, the use of variable nanocarriers for dermal application has been widely explored, as they offer several advantages compared with conventional topical preparations, including higher skin penetration, controlled and targeted drug delivery and the achievement of higher therapeutic effects. This article will focus on skin inflammation or dermatitis as it is one of the most common skin problems, describing the different types and causes of dermatitis, as well as the typical treatment regimens. The potential use of nanocarriers for targeting skin inflammation and the achievement of higher therapeutic effects using nanotechnology will be explored.

Entities:  

Keywords:  animal models; dermatitis; glucocorticoids; hair follicles; nanoparticles; skin inflammation; skin penetration; targeting

Mesh:

Substances:

Year:  2014        PMID: 25321172     DOI: 10.2217/nnm.14.74

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  7 in total

1.  Combined Action of Human Commensal Bacteria and Amorphous Silica Nanoparticles on the Viability and Immune Responses of Dendritic Cells.

Authors:  Giulia Malachin; Elisa Lubian; Fabrizio Mancin; Emanuele Papini; Regina Tavano
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

2.  Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.

Authors:  M Giulbudagian; G Yealland; S Hönzke; A Edlich; B Geisendörfer; B Kleuser; S Hedtrich; M Calderón
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 3.  MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.

Authors:  Sandra Domingo; Cristina Solé; Teresa Moliné; Berta Ferrer; Josefina Cortés-Hernández
Journal:  Cells       Date:  2020-12-10       Impact factor: 6.600

Review 4.  Challenges in the Physical Characterization of Lipid Nanoparticles.

Authors:  Supandeep Singh Hallan; Maddalena Sguizzato; Elisabetta Esposito; Rita Cortesi
Journal:  Pharmaceutics       Date:  2021-04-14       Impact factor: 6.321

5.  A spectrofluorometric analysis to evaluate transcutaneous biodistribution of fluorescent nanoparticulate gel formulations.

Authors:  Enrica Cappellozza; Federico Boschi; Maddalena Sguizzato; Elisabetta Esposito; Rita Cortesi; Manuela Malatesta; Laura Calderan
Journal:  Eur J Histochem       Date:  2022-02-07       Impact factor: 3.188

6.  Biologically Synthesized Rosa rugosa-Based Gold Nanoparticles Suppress Skin Inflammatory Responses via MAPK and NF-κB Signaling Pathway in TNF-α/IFN-γ-Induced HaCaT Keratinocytes.

Authors:  Rongbo Wang; Sung-Kwon Moon; Woo-Jung Kim; Sanjeevram Dhandapani; Hoon Kim; Yeon-Ju Kim
Journal:  ACS Omega       Date:  2022-09-30

Review 7.  Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.

Authors:  Salma A Fereig; Ghada M El-Zaafarany; Mona G Arafa; Mona M A Abdel-Mottaleb
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.